BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VEVENT UID:45eb3d50cd6d4c3acbc2c64e4fad2404 CATEGORIES:Colloquium CREATED:20170816T174635 SUMMARY:Fall 2017 Colloquium: Professor Adam Gormley DESCRIPTION:
Tuesday October 10, 2017
Platform bionanotechnologies for the development of therapeutics and diagnostics
Advancements in drug and diagnostic development have enabled significan t gains in medicine and medical technology. Case-in-point, the biotechnolog y industry which has benefited from fundamental advancements in genetic eng ineering. Nanotechnology and its toolbox of nanoparticles, polymers, peptid es and nucleic acids offers tremendous potential for similar medical advanc ements. In this talk, Dr. Gormley will outline efforts to develop new thera peutic and diagnostic platform technologies by leveraging the self-assembly of these nanoscale components. Examples will include: 1) coiled-coil self- assembled drug carriers; 2) polymerization-amplified detection for nanopart icle-based biosensing; as well as 3) new and ongoing work in high-throughpu t discovery of well-defined polymeric drugs. The development of these funda mental platform technologies and others will play an instrumental role in f uture medical technologies that will increasingly rely on tools at the nano scale.
~Coffee/tea will be served prior to lecture.~
X-ALT-DESC;FMTTYPE=text/html:Tuesday October 10, 2017
Wright-Reiman Labs Room 260
Platform bionanotechnologies for the development of the rapeutics and diagnostics
Advancements in drug and diagnostic develop ment have enabled significant gains in medicine and medical technology. Cas e-in-point, the biotechnology industry which has benefited from fundamental advancements in genetic engineering. Nanotechnology and its toolbox of nan oparticles, polymers, peptides and nucleic acids offers tremendous potentia l for similar medical advancements. In this talk, Dr. Gormley will outline efforts to develop new therapeutic and diagnostic platform technologies by leveraging the self-assembly of these nanoscale components. Examples will i nclude: 1) coiled-coil self-assembled drug carriers; 2) polymerization-ampl ified detection for nanoparticle-based biosensing; as well as 3) new and on going work in high-throughput discovery of well-defined polymeric drugs. Th e development of these fundamental platform technologies and others will pl ay an instrumental role in future medical technologies that will increasing ly rely on tools at the nanoscale.
~Coffee/tea will be served prior to lecture.~
DTSTAMP:20240328T205341 DTSTART:20171010T150000 DTEND:20171010T160000 SEQUENCE:0 TRANSP:OPAQUE END:VEVENT END:VCALENDAR